Provided by Tiger Trade Technology Pte. Ltd.

Regeneron Pharmaceuticals

758.27
+7.761.03%
Post-market: 759.060.7900+0.10%18:15 EDT
Volume:872.42K
Turnover:659.47M
Market Cap:78.07B
PE:18.75
High:763.72
Open:749.84
Low:742.94
Close:750.51
52wk High:859.34
52wk Low:541.00
Shares:102.95M
Float Shares:98.88M
Volume Ratio:1.13
T/O Rate:0.88%
Dividend:3.64
Dividend Rate:0.48%
EPS(TTM):40.43
EPS(LYR):41.48
ROE:14.04%
ROA:6.53%
PB:2.46
PE(LYR):18.28

Loading ...

Regeneron Drug Halves Muscle Loss in Combination with Novo's Semaglutide in Trial

Reuters
·
36 mins ago

Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
1 hour ago

Regeneron Links 2026 CEO, CSO PSU Awards to FDA Filings, Approvals and New-Product Revenue Targets Through 2035

Reuters
·
2 hours ago

Regeneron’s ALN-F1202 Safety Trial Marks a Quiet but Important Pipeline Milestone

TIPRANKS
·
6 hours ago

Citi Tells Investors It's Time to Sell Moderna After 600%-Plus Stock Gains

Dow Jones
·
Yesterday

Regeneron Needs 'Better' Terms in Sanofi Renegotiation, RBC Says

MT Newswires Live
·
Yesterday

Analysts Offer Insights on Healthcare Companies: Summit Therapeutics (SMMT), Ocular Therapeutix (OCUL) and Regeneron (REGN)

TIPRANKS
·
Sep 29

Court Dismisses Regeneron Pharmaceuticals (REGN) Securities Lawsuit Over Eylea and Eylea HD Claims

TIPRANKS
·
Sep 29

Analysts Conflicted on These Healthcare Names: 4D Molecular Therapeutics (FDMT), Envista Holdings (NVST) and Regeneron (REGN)

TIPRANKS
·
Sep 29

$20 Billion In Deals And Counting: Lilly's CEO Targets The "White Space" Of Science For Larger M&A

Options & Short Sell
·
Sep 29

AstraZeneca To Invest $2 Billion In Summit And Co-Develop Drugs; Shares Jump After Hours

Options & Short Sell
·
Sep 29

Regeneron Pharmaceuticals Inc. Stock Falls 4.5%, Underperforms Peers

Dow Jones
·
Sep 29

Ocular Therapeutix Tumbles on Rival Kodiak's Trial Win, Analyst Calls Selloff Overdone

Reuters
·
Sep 29

Analysts Offer Insights on Healthcare Companies: Regeneron (REGN) and Kodiak Sciences (KOD)

TIPRANKS
·
Sep 29

Inside the Eye-Drug Breakthrough That Sent Kodiak Sciences up 156%

Dow Jones
·
Sep 28

US Drugmakers Turn to China for Licensing Deals

Reuters
·
Sep 28

Movement Alert|Regeneron Pharmaceuticals Falls 3.52% in Regular Trading, Trading at $760.15

Market Focus
·
Sep 28

Kodiak Sciences Rises After Eye-Disease Drugs Meet Trial Goals

Reuters
·
Sep 28

Regeneron (REGN) Receives a Hold from Bernstein

TIPRANKS
·
Sep 26

Analysts Are Bullish on Top Healthcare Stocks: Agilent (A), Regeneron (REGN)

TIPRANKS
·
Sep 26